NXS 0.00% 20.0¢ next science limited

Ann: Investor Presentation, page-11

  1. 142 Posts.
    lightbulb Created with Sketch. 33
    I agree with your very bullish outlook @Tarvold IMHO especially when you look at the range of products NXS already has in the market and the plethora of new products to come. I can see a time when NXS' products will be recognised Worldwide as the Gold standard for treating antibiotic resistant infections and that their products will become a household name like Betadine IMHO DYOR It may take some time, due to the medical profession's rightfully cautious approach to taking up new products but, over time, I believe NXS has significant potential in the long run.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $58.43M
Open High Low Value Volume
20.5¢ 20.5¢ 20.0¢ $42.76K 213.6K

Buyers (Bids)

No. Vol. Price($)
1 18228 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 12000 1
View Market Depth
Last trade - 16.10pm 29/08/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.